GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting
The STEP 4 trial showed that patients who stopped semaglutide began regaining weight, whereas those who continued treatment maintained or further reduced their weight
Instead of managing separate products, this format allows for a more streamlined routine
doi:10.1016/j.jdiacomp.2013.04.006 Kluger N, Jaczynska K, Witkowska-Sedek E, et al
In a meta-analysis of prospective cohort studies, higher vitamin E intakes from diet and supplements combined were associated with lower risks of dementia (13 studies) and AD (8 studies) (103)
They helped her ease into treatment at a pace her body could handle while keeping her closely connected with her clinician and coach